The use of COVID-19 vaccines has been associated with sporadic reports of thrombosis with thrombocytopenia, a complication referred to as vaccine-induced immune thrombotic thrombocytopenia (VITT). Early recognition of this entity before the occurrence of thrombosis detected by imaging is termed as a pre-VITT syndrome. Thrombosis has been reported to occur in the cerebral venous system, splanchnic veins as well as arteries to the lower limbs. We present the case of a young renal transplant recipient who presented with VITT following ChAdOx1 nCoV-19 (Covishield) vaccination; in this case, thrombosis occurred in the intrarenal arteries of the graft kidney.
No takes yet. Share an insight, caveat, or question.
Shahanas et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: